当前位置: 首页 > 详情页

Allicin reduces IL-1 beta-induced inflammatory cytokines via attenuating the NF-kappa B and MMP3 activation in human osteoarthritis chondrocytes model

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Orthopaed, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China
出处:
ISSN:

关键词: Allicin osteoarthritis chondrocytes COX-2 IL-1 beta PGE2 NF-kappa B

摘要:
Allicin, a sulphur containing compound isolated from the bulb of Allium sativum, confirm the various pharmacological activity such as antioxidant and antiinflammatory effects. The current study was intended to evaluate the effect of allicin on the IL-1 beta-Induced inflammatory cytokines in Human Osteoarthritis Chondrocytes. The chondrocytes were stimulated with IL-1 beta in the presence or absence of allicin. Moreover, the western blot analyses was used for the estimation of the nuclear factor-kappa B (NF-kappa B), c-Jun N-terminal kinase (JNK), cyclooxygenase-2 (COX-2), inhibitory kappa B (I kappa B alpha), extracellular signal-regulated kinase (ERK), iNOS and p38 expression. The level of PGE(2) and NO production in the IL-1 beta treatment were determined via using the ELISA and Griess reagent. In the current study, allicin was found to be significantly inhibited the IL-1 beta induced iNOS and COX-2 expression in dose dependent manner. On the other hand, allicin in dose-dependent manner causes significant (P<0.01) reduction of the IL-1 beta-induced PGE(2), NO and collagenase-3 (MMP-13) production. Allicin also showed significant reduction of the IL-1 beta-induced mitogen-activated protein kinase (MAPK) and NF-kappa B activation. In conclusion, allicin showed efficient attenuation of the osteoarthritis chondrocytes inflammatory response triggered by IL-1 beta. The result of the current study confirmed that allicin may be beneficial agent in the management or control of osteoarthritis.

语种:
WOS:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
JCR分区:
出版当年[2014]版:
Q3 PATHOLOGY Q3 ONCOLOGY
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY Q4 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Orthopaed, Beijing 100050, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Orthopaed, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院